Resilia Inc

Resilia Inc. manufactures and sells uresta®, the only reusable, self-managed medical device for female stress urinary incontinence that has been clinically proven to completely eliminate or significantly reduce the involuntary loss of urine. FDA cleared, licensed under Health Canada, and CE marked, with global patents on the device, uresta® is the only reusable, highly effective, and self-managed solution available. uresta® is currently available for sale in Canada at uresta.com and can be purchased in the UK, US, Germany, & Turkey. For information about the uresta® solution please visit uresta.com or contact us at 506-531-0183. Incontinence Market: Estimated to be the fastest growing personal hygine segment in North America, the demand for incontinence solutions is being driven by an ageing population with a relatively long life expectancy and higher disposable incomes. It is estimated that one out of every three women will suffer incontinence in their lifetime and 60% of those will suffer from stress urinary incontinence ("SUI"). The health care costs of treating SUI are tremendous, and while the condition is common, it is not normal, and is associated with medical and psychological morbidity, that has a very real, adverse effect on the quality of life for a suffer. A cultural shift that is reducing the stigma regarding incontinence together with a willingness by mainstream media to discuss the issue means sales growth of incontinence solutions is expected to continue to outpace all other personal hygiene product categories.

• Employees4
• Founded2014
• Annual Revenue$550000
• Total Funding$2102019